Keros Therapeutics (KROS) EBIT (2019 - 2026)
Keros Therapeutics (KROS) reported EBIT of -$30.94 million for Q2 2026, compared with -$39.82 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) EBIT (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Keros Therapeutics' EBIT came in at -$115.41 million; for FY2025, it was $67.57 million.
- By year, EBIT came in at -$210.83 million in FY2024, -$169.94 million in FY2023, -$114.79 million in FY2022 and -$56.37 million in FY2021.
- Five-year quarterly EBIT spans a low of -$58.66 million in Q3 2024 and a high of $152.04 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,168.10 Bn | 1,136.68 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 643.43 Bn | 561.95 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 500.92 Bn | 474.03 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 360.47 Bn | 314.85 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 302.41 Bn | 266.40 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 267.36 Bn | 241.05 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 241.30 Bn | 196.70 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 192.97 Bn | 167.17 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.65 Bn | 118.30 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Keros Therapeutics | 223.15 Mn | -1.71 Bn | - | -30.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.94 Mn |
| Dec 31, 2025 | -29.27 Mn |
| Sep 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | -39.82 Mn |
| Mar 31, 2025 | 152.04 Mn |
| Dec 31, 2024 | -53.25 Mn |
| Sep 30, 2024 | -58.66 Mn |
| Jun 30, 2024 | -50.44 Mn |
| Mar 31, 2024 | -48.48 Mn |
| Dec 31, 2023 | -46.46 Mn |
| Sep 30, 2023 | -43.28 Mn |
| Jun 30, 2023 | -41.34 Mn |
| Mar 31, 2023 | -38.87 Mn |
| Dec 31, 2022 | -31.96 Mn |
| Sep 30, 2022 | -27.98 Mn |
| Jun 30, 2022 | -30.73 Mn |
| Mar 31, 2022 | -24.13 Mn |
| Dec 31, 2021 | -4.87 Mn |
| Sep 30, 2021 | -20.20 Mn |
| Jun 30, 2021 | -15.54 Mn |
API Access
Keros Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();